Pharmacokinetics and preliminary safety data of a single oral dose of bosentan, a dual endothelin receptor antagonist, in cats.

Puza, N; Papich, M G; Reinero, C; Chang, C H; Yu, D-H; Sharp, C; DeClue, A

Puza, N; Papich, M G; Reinero, C; Chang, C H; Yu, D-H; Sharp, C; DeClue, A.

J Vet Pharmacol Ther ; 37(2): 192-5, 2014 Apr.

Article in En | MEDLINE | ID: mdl-24745065

Subject(s)

Antihypertensive Agents/pharmacokinetics; Cats/blood; Sulfonamides/pharmacokinetics; Administration, Oral; Animals; Antihypertensive Agents/administration & dosage; Antihypertensive Agents/adverse effects; Bosentan; Half-Life; Male; Statistics as Topic; Sulfonamides/administration & dosage; Sulfonamides/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Cats / Antihypertensive Agents Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Vet Pharmacol Ther Year: 2014 Document type: Article Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links